Crocin protects against smoke-induced chronic obstructive pulmonary disease by regulating AKT1
Yuehong Zhu1,2, Yuntao Jiang1,3, Jieping Xu1,3
1Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China.
Frontiers in pharmacology
|February 25, 2026
まとめ
Crocin shows therapeutic potential for chronic obstructive pulmonary disease (COPD) by reducing inflammation and regulating AKT1. This study validates its effects using a multidimensional approach, overcoming potential non-specific compound activity.
科学分野:
- 薬理学; 計算生物学; 呼吸器医学
背景:
- 慢性閉塞性肺疾患（COPD）は、気道炎症とリモデリングを伴い、新規治療標的が必要とされています。; サフラン由来のCrocinは潜在的な治療効果を示しますが、解釈を複雑にする可能性のあるパンアッセイ干渉化合物（PAINS）様特性を持つ可能性があります。; COPDにおけるCrocinの効果を検証するには、多次元戦略が不可欠です。
研究 の 目的:
- COPDに関連するCrocinの分子ターゲットを特定すること。; COPDモデルにおけるCrocinの治療効果を調査すること。; PAINS特性の可能性を考慮してCrocinの作用機序を検証すること。
主な方法:
- ネットワーク分析により、CrocinとCOPDの間の共通ターゲットが特定されました。; 分子ドッキングおよび動力学シミュレーションにより、Crocin-ターゲット相互作用が評価されました。; In vitro（CETSA）およびin vivo（マウスモデル）実験により、Crocinの有効性と作用機序が評価されました。
主要な成果:
- ネットワーク分析により48個の共通ターゲットが予測され、PI3K-AKT経路が強調されました。; CrocinはAKT1に対して良好な結合を示し、分子動力学およびCETSAによって確認されました。; In vivo研究により、COPDマウスモデルにおいてCrocinの抗炎症効果とAKT1の調節が実証されました。
結論:
- Crocinは、抗炎症作用とAKT1調節を介してCOPDの治療可能性を示します。; ネットワーク、in vitro、およびin vivoの組み合わせデータは、Crocinの生物学的関連性を支持します。; 本研究は、PAINS特性に関する懸念を軽減し、Crocinの効果の堅牢な検証を提供します。
関連する概念動画
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:20COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
01:24Chronic Obstructive Pulmonary Disease
2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:26COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K